Wells Fargo & Company Bio Rad Laboratories, Inc. Transaction History

Wells Fargo & Company

  • $434 Billion
  • Q3 2024

A detailed history of Wells Fargo & Company transactions in Bio Rad Laboratories, Inc. stock. As of the latest transaction made, Wells Fargo & Company holds 170 shares of BIO-B stock, worth $0. This represents 0.0% of its overall portfolio holdings.

Number of Shares
170
Previous 170 -0.0%
Holding current value
$0
Previous $0 NaN%
% of portfolio
0.0%
Previous 0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 15, 2023
BUY
N/A
114 Added 203.57%
170 $0
Q1 2020

May 14, 2020
BUY
N/A
56 New
56 $20,000

Others Institutions Holding BIO-B

# of Institutions
7
Shares Held
3.33K
Call Options Held
0
Put Options Held
0
View Full List

About Bio-Rad Laboratories, Inc.

BIO-B Quotes by TradingView
  • Ticker BIO-B
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 5,063,720
  • Market Cap $11.2B
More about BIO-B
Track This Portfolio

Track Wells Fargo & Company Portfolio

Follow Wells Fargo & Company and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

News

Stay updated on Wells Fargo & Company with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email